Connect with us

Health

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients – News-Medical.Net

A team of researchers from the US and the Netherlands recently reported that antibodies to the spike protein and the RBD are detected in saliva samples from healthcare…

Published

on

Article feature image

Vaccines are very important in controlling the coronavirus disease 2019 (COVID-19) pandemic. Two highly effective mRNA vaccines are available in the USA – mRNA-1273 from Moderna and BNT162b2 from Pfizer/BioNTech. These vaccines elicit antibodies to the spike protein of COVID-19’s causative virus,  severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These include neutralizing antibodies (NAbs) that are directed against the receptor-binding domain (RBD). Serum NAbs are triggered at lower…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending